Metis TechBio Co (HKSE:07666) ROCE %: -50.45% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:07666 Metis TechBio Co Ltd HKSE:07666
6 GF Score
Price HK$12.24
! 1 Warning Sign
View Full Analysis

What is Metis TechBio Co ROCE %?

Metis TechBio Co HKSE:07666 +2.00% 6 ROCE % is -50.45% as of Dec. 2025. GuruFocus rates HKSE:07666 with a GF Score™ of 6/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Metis TechBio Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -50.45%.

Metis TechBio Co  (HKSE:07666) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Metis TechBio Co ROCE % Related Terms

Metis TechBio Co ROCE % Historical Data

* Premium members only.

The historical data trend for Metis TechBio Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metis TechBio Co ROCE % Chart

Metis TechBio Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
-6,743.35 -83.97 -30.28 -35.53

Metis TechBio Co Quarterly Data
Dec22 Dec23 Dec24 Sep25 Dec25
ROCE % 0.00 0.00 -29.01 0.00 -50.45
HKSE:07666
6GF Score
Metis TechBio Co Ltd HKSE:07666
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metis TechBio Co ROCE % Calculation

Metis TechBio Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-397.598/( ( (1119.492 - 116.831) + (1425.391 - 190.243) )/ 2 )
=-397.598/( (1002.661+1235.148)/ 2 )
=-397.598/1118.9045
=-35.53 %

Metis TechBio Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=-636.584/( ( (1475.906 - 187.466) + (1425.391 - 190.243) )/ 2 )
=-636.584/( ( 1288.44 + 1235.148 )/ 2 )
=-636.584/1261.794
=-50.45 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -50.45% mean?
Metis TechBio Co (HKSE:07666) has a ROCE % of -50.45% as of Dec. 2025.
Is Metis TechBio Co's ROCE % too high?
Metis TechBio Co's current ROCE % is -50.45%. Overall, Metis TechBio Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Metis TechBio Co's ROCE % compare to VRTX and REGN?
Metis TechBio Co's ROCE % of -50.45% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Metis TechBio Co's current ROCE % is -50.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metis TechBio Co stock overvalued right now?
Metis TechBio Co (HKSE:07666) has a current ROCE % of -50.45%. The current ROCE % is -50.45%. Metis TechBio Co's overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Metis TechBio Co (HKSE:07666), the current ROCE % is -50.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metis TechBio Co Business Description

Other Exchanges RO9:Germany
Address No. 21 Tianhe West Road, Room 201, 2nd Floor, Building 13, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing, CHN
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
6GF Score

Get the complete analysis for HKSE:07666

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.24
Price